Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor (original) (raw)
References
Ashorn P, McQuade TJ, Thaisrivongs S, Tomaselli AG, Tarpley WG, Moss B (1990) An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. Proc Natl Acad Sci USA 87: 7472–7476 Google Scholar
Clavel F, Orenstein JM (1990) A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J Virol 64: 5230–5234 Google Scholar
Coombs RW, Collier AC, Allain JP, Nikora B, Leuther M, Gjerset GF, Corey L (1989) Plasma viremia in human immunodeficiency virus infection. N Engl J Med 321: 1626–1631 Google Scholar
Erickson J, Neidhardt DJ, VanDrie J, Kempf DJ, Wank XC, Norbeck DW, Plattner JJ, Rittenhouse JW, Turon M, Wideburg N, Kohlbrenner WE, Simmer R, Helfrich R, Paul DA, Knigge M (1990) Design, activity, and 2.8 Å crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. Science 249: 527–533 Google Scholar
Gelderblom HR, Hausmann EHS, Özel M, Pauli G, Koch MA (1987) Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156: 171–176 Google Scholar
Gelderblom HR, Özel M, Pauli G (1989) Morphogenesis and morphology of HIV: structure-function relations. Arch Virol 106: 1–13 Google Scholar
Gelderblom HR, Marx PA, Özel M, Gheysen D, Munn RJ, Joy KI, Pauli G (1990) Morphogenesis, maturation and fine structure of lentiviruses. In: Pearl LH (ed) Retroviral proteases: maturation and morphogenesis. Macmillan, London, pp 159–181 Google Scholar
Hansen J, Billich S, Schulze T, Sukrow S, Moelling K (1988) Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody. EMBO J 7: 1785–1791 Google Scholar
Ho DD, Mougdil T, Alam M (1989) Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 321: 1621–1625 Google Scholar
Kohl NE, Emini EA, Schleif WA, Davis EJ, Heimbach JC, Dixon RAF, Scolnick EM, Sigal IS (1988) Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci USA 85: 4686–4690 Google Scholar
Kräusslich HG, Oroszlan S, Wimmer E (ed) (1989) Viral proteinases as targets for chemotherapy. Cold Spring Harbor Laboratory, Cold Spring Harbor Google Scholar
Kräusslich HG, Schneider H, Zybarth G, Carter CA, Wimmer E (1989) Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in_Escherichia coli_. J Virol 62: 4393–4397 Google Scholar
McQuade TJ, Tomasselli AG, Liu L, Karacostas V, Moss B, Sawyer TK, Heinrikson RL, Tarpley WG (1990) A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. Science 247: 454–456 Google Scholar
Meek TD, Lambert DM, Dreyer GB, Carr TJ, Tomaszek TA Jr., Moore ML, Strickler JE, Debouck C, Hyland LJ, Matthews TJ, Metcalf BW, Petteway SR (1990) Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues. Nature 343: 90–92 Google Scholar
Peng C, Ho BK, Chang TW, Chang NT (1989) Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. J Virol 63: 2550–2556 Google Scholar
Roberts NA, Martin JA, Kinchington D, Broadhurst AV, Craig JC, Duncan IB, Galpin SA, Handa BK, Kay J, Kröhn A, Lambert RW, Merrett JH, Mills JS, Parkes KEB, Redshaw S, Ritchie AJ, Taylor DL, Thomas GJ, Machin PJ (1990) Rational design of peptide-based HIV proteinase inhibitors. Science 248: 358–361 Google Scholar
Schneider J, Kent SBH (1988) Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease. Cell 54: 363–368 Google Scholar
Seelmeier S, Schmidt H, Turk V, von der Helm K (1988) Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A. Proc Natl Acad Sci USA 85: 6612–6616 Google Scholar
Stewart L, Schatz G, Vogt VM (1990) Properties of avian retrovirus particles defective in viral protease. J Virol 64: 5076–5092 Google Scholar
Von der Helm K, Gürtler L, Eberle J, Deinhardt F (1989) Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A. FEBS Lett 247: 349–352 Google Scholar